Amplexa Genetics A/S

The times they are a changing when hasnt that been true words? In the field of genetics, testing is becoming increasingly affordable, new techniques constantly available, knowledge about genes increasing and the public ready to take action regarding their own health. Public health politics have for many years talked about and tried to take action on prevention. Genetic prevention is not part of these deliberations and most often not considered a possibility, except in very few hereditary conditions. Amplexas statement is that a person has a right to know his or her genetic make-up in order to be able to...

Clinical genetic analysis,genetic screening,preconception screening,fertility genetics,carrier screening,diagnostic testing,clinical genetics,genetic research,research,epilepsy [childhood epilepsy,progressive myoclonic epilepsy,brain malformation],endocrinology [osteogeneses imperfecta; familial hypercholesterolemia,rickets],oncology [lynch syndrome/hnpcc,breast and ovarian cancer],neurology,corona testing,and covid19 testing

Amplexa genetics a/s operates in the Hospitals and health care industry.

Amplexa genetics a/s's revenue is 11m - 100m

Amplexa genetics a/s has 11 - 50 employees.